Thiogenesis Therapeutics, Corp. Share Price
Equities
TTI
CA88410L1022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 CAD | 0.00% | -5.41% | -6.67% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 31.85M 23.31M 1.83B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.96% |
1 week | -5.41% | ||
Current month | -2.78% | ||
1 month | -6.67% | ||
3 months | -12.50% | ||
6 months | -12.50% | ||
Current year | -6.67% |
Managers | Title | Age | Since |
---|---|---|---|
Patrice Rioux
FOU | Founder | 73 | 31/12/17 |
Brook Riggins
DFI | Director of Finance/CFO | 58 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kim Tsuchimoto
BRD | Director/Board Member | 61 | 30/03/22 |
Chairman | 71 | 30/03/22 | |
Brook Riggins
DFI | Director of Finance/CFO | 58 | - |
Date | Price | Change | Volume |
---|---|---|---|
28/05/24 | 0.7 | 0.00% | 500 |
24/05/24 | 0.7 | -1.41% | 12,000 |
23/05/24 | 0.71 | -2.74% | 20,000 |
22/05/24 | 0.73 | -1.35% | 42,000 |
Delayed Quote Toronto S.E., May 28, 2024 at 03:59 pm
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.67% | 23.35M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+37.57% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- TTI Stock